Delivery Order SPE2DB20D1100-SPE2DB24FA8Y8
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $7,019.00, is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML medical supplies. The award is a Delivery Order with a Firm Fixed Price valued at $21,163.20 and has a completion date of September 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to...
- This federal contract award, valued at $18,245.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a medical product, with a completion date of May 9, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $10,934.32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is a firm-fixed-price delivery order for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued at up to $999,999,999.00, which serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $3,527.20 firm fixed price delivery order is for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML, with a performance period through April 24, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025....
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $10,947.00, is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML medical supplies. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,298.00 firm fixed-price delivery order is for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML medical products, with a performance period through March 18, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
- This federal contract award, valued at $7,019.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4560168561 - GEL-ONE 30 MG/3 ML SYRINGE 3ML, with an ultimate completion date of March 14, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
- This federal contract award to Amerisourcebergen Drug Corp was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $25,395.84 delivery order is for the supply of 4,566,078,188 units of the GEL-ONE 30 MG/3 ML SYRINGE 3ML pharmaceutical product. The award is not designated as a set-aside contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999, for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $87,400.00, is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML medical supplies. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The contract is a Delivery Order under an Indefinite Delivery...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FA8Y8Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is a delivery order valued at $21,163.20 for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and has received numerous similar awards from DLA Troop Support Medical to provide pharmaceuticals, medical supplies, and related distribution services in support of military treatment programs and facilities. Additionally, Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.2k | 3/22/24 |